Progress in neuropathology of the neuronal ceroid lipofuscinoses
- PMID: 10191130
- DOI: 10.1006/mgme.1999.2808
Progress in neuropathology of the neuronal ceroid lipofuscinoses
Abstract
Since the last, 6th, International Congress on Neuronal Ceroid-Lipofuscinoses, neuropathological advances in neuronal ceroid lipofuscinoses (NCL) have been made in several areas: (1) In adult NCL (ANCL) lipopigments have now been repeatedly confirmed to contain subunit c of mitochondrial ATP synthase and even sphingolipid activators (saposins). ANCL lipopigments have also been confirmed in extracerebral tissues including skin, skeletal muscle, and spleen, but not yet lymphocytes (2). Among circulating blood cells not only B cells and subclasses of T lymphocytes, i.e., CD4(+), CD8(+), and CD56 cells, but also monocytes have been found to contain NCL lipopigments, indicating that this precursor cell in the digesting macrophage system also has an impaired metabolic catabolism for lipopigments (3). Immunohistochemical studies indicate that microglial reaction in NCL brain is limited to resident microglia without contribution by circulating monocytes (4). The granular osmiophilic deposit (GROD) type of NCL has now been established not only in infantile, but also in late-infantile, juvenile, and protracted-juvenile NCL (5). A European Tissue Registry established within the framework of a European Concerted Action on Neuronal Ceroid-Lipofuscinosis may form the basis for additional collaborative studies on NCL, including both biopsy and autopsy tissues.
Copyright 1999 Academic Press.
Similar articles
-
Human pathology in NCL.Biochim Biophys Acta. 2013 Nov;1832(11):1807-26. doi: 10.1016/j.bbadis.2012.11.014. Epub 2012 Nov 29. Biochim Biophys Acta. 2013. PMID: 23200925 Review.
-
Diagnoses of neuronal ceroid-lipofuscinosis by immunochemical methods.Am J Med Genet. 1995 Jun 5;57(2):239-45. doi: 10.1002/ajmg.1320570226. Am J Med Genet. 1995. PMID: 7668338
-
Morphologic studies on adult neuronal-ceroid lipofuscinosis (NCL).Clin Neuropathol. 1982;1(4):151-62. Clin Neuropathol. 1982. PMID: 7168921
-
[Batten disease (Neuronal ceroid lipofuscinoses)--accumulation of ATP synthase subunit c caused by the delay of lysosomal degradation].Nihon Rinsho. 1995 Dec;53(12):3055-61. Nihon Rinsho. 1995. PMID: 8577058 Review. Japanese.
-
Sphingolipid activator proteins (SAPs) in neuronal ceroid lipofuscinoses (NCL).Neuropediatrics. 1997 Feb;28(1):49-52. doi: 10.1055/s-2007-973667. Neuropediatrics. 1997. PMID: 9151322 Review.
Cited by
-
Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease.Mol Cell Biol. 2006 Mar;26(6):2309-16. doi: 10.1128/MCB.26.6.2309-2316.2006. Mol Cell Biol. 2006. PMID: 16508006 Free PMC article.
-
Lysosomal Storage Diseases-Regulating Neurodegeneration.J Exp Neurosci. 2016 Apr 5;9(Suppl 2):81-91. doi: 10.4137/JEN.S25475. eCollection 2015. J Exp Neurosci. 2016. PMID: 27081317 Free PMC article. Review.
-
Neuron-astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation.Clin Exp Neuroimmunol. 2015 Aug;6(3):245-263. doi: 10.1111/cen3.12237. Epub 2015 Aug 3. Clin Exp Neuroimmunol. 2015. PMID: 26543505 Free PMC article.
-
A novel pathogenic variant in the KCTD7 gene in a patient with neuronal ceroid lipofuscinosis (CLN14): a case report and review of the literature.BMC Neurol. 2024 Sep 30;24(1):367. doi: 10.1186/s12883-024-03868-w. BMC Neurol. 2024. PMID: 39350080 Free PMC article. Review.
-
Patient-Derived Induced Pluripotent Stem Cell Models for Phenotypic Screening in the Neuronal Ceroid Lipofuscinoses.Molecules. 2021 Oct 15;26(20):6235. doi: 10.3390/molecules26206235. Molecules. 2021. PMID: 34684815 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous